Quaker Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,382
Closed -$145K 976
2025
Q1
$145K Buy
+2,382
New +$139K 0.05% 81

Other funds holding BMY

Quaker Wealth Management's BMY Position: Q2 2026 in Review

Quaker Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 12% in Q2 2026, buying an estimated $12.8K and bringing the position to 2,138 shares worth $123K. The position accounts for 0.04% of the portfolio, ranked #98.

Quaker Wealth Management first reported a position in BMY in Q4 2019 and has held it in 16 quarters since. The position peaked at $344K in Q3 2023. 865 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Quaker Wealth Management held 2,138 shares of Bristol-Myers Squibb worth $123K as of Q2 2026.
  • Quaker Wealth Management bought 223 Bristol-Myers Squibb shares in Q2 2026, an estimated $12.8K.
  • Bristol-Myers Squibb made up 0.04% of Quaker Wealth Management's portfolio in Q2 2026, its #98 holding.
  • Quaker Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 16 quarters since.
  • Quaker Wealth Management's Bristol-Myers Squibb position peaked at $344K in Q3 2023.
  • 865 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.